Skip to main content

Table 1 Baseline characteristics

From: Clinical results of multidisciplinary therapy including palliative posterior spinal stabilization surgery and postoperative adjuvant therapy for metastatic spinal tumor

Characteristic Value
Patients, n 55
Age at surgery, mean (range), years 66.8 (26–92)
Sex, n (%)
 Male 37 (67.2)
 Female 18 (32.7)
Metastatic tumor diagnosis, n (%)  
 Lung 11 (20.0)
 Liver 9 (16.3)
 Prostate 6 (10.9)
 Myeloma 5 (9.0)
 Kidney 4 (7.2)
 Thyroid 4 (7.2)
 Lymphoma 3 (5.4)
 Gallbladder 3 (5.4)
 Breast 2 (3.6)
 Sarcoma 2 (3.6)
 Others 5 (9.0)
 Unknown 1 (1.8)
Main level of tumors, n (%)
 Cervical 9 (16.3)
 Thoracic 32 (58.1)
 Lumbar 14 (25.4)
Preoperative modified Frankel category, n (%)
 A 2 (3.6)
 B 1 (1.8)
 C 19 (34.5)
 D1 15 (27.2)
 D2 1 (1.8)
 D3 10 (18.1)
 E 7 (12.7)
Visual analogue scale (range) 4.6 (1–10)
Tokuhashi score, n (%)
 0–8 40 (72.7)
 9–11 9 (16.3)
 12–15 6 (10.9)
Spinal instability neoplastic score, n (%)
 0–6 6 (10.9)
 7–12 48 (87.2)
 13–18 1 (1.8)
Epidural spinal cord compression scale, n (%)
 0 1 (1.8)
 1a 4 (7.2)
 1b 4 (7.2)
 1c 3 (5.4)
 2 23 (41.8)
 3 20 (36.3)
Preoperative Barthel index, mean (range) 48.7 (0–100)